ROS1 and angiosarcoma: However, only the primary angiosarcoma specimen, AS1, exhibited a prominent and highly significant (P<10−27) expression transition (Figure 2A), with the predicted breakpoint corresponding to known rearrangements of ROS1 in other malignancies.